Investment Banks for Healthcare Deals
We analyzed eight leading healthcare M&A advisory firms serving middle-market sellers: founder-owned practices and PE-backed platforms with enterprise values between $20M–$1B. These firms represent many of the most visible advisory brands healthcare owners encounter when exploring a sale. This article reflects our opinions, based generally on market reputation and our analysis of publicly available information.
Healthcare deal volume & recency: How consistently the firm closes healthcare M&A deals in the current market cycle
Middle-market focus & deal size alignment: Fit for founder-owned and sponsor-backed companies, especially where senior attention matters
Healthcare subsector coverage: Breadth across services, HCIT, life sciences, devices, provider models, and payor-adjacent segments
Buyer network strength (PE & strategics): Ability to drive competitive tension with relevant PE sponsors and strategic buyers
Process transparency & thought leadership: Clarity, preparedness, seller education, and visible market insight that improves decision-making
Disclaimer: This analysis reflects our opinion based on publicly available information and market research. It is for informational purposes only, does not constitute investment advice, and does not guarantee outcomes. Readers should conduct their own due diligence when selecting an investment bank.
| Firm | Good Fit For |
|---|---|
| FOCUS Investment Banking | Founder-led and PE-backed middle-market healthcare exits from $20M to $200M |
| Houlihan Lokey | High-volume mid-market processes, global sponsor coverage. Best for larger PE-backed groups. |
| KeyBanc Capital Markets (Cain Brothers) | Provider-heavy and healthcare services, HCIT-heavy mandates |
| Harris Williams | Sponsor-backed healthcare services and tech-enabled models |
| Robert W. Baird & Co. | Relationship-driven mid-market advisory with broad healthcare reach |
| Rothschild & Co. | Europe-forward mandates, independence-driven advisory |
| J.P. Morgan | Mega-deals and complex global strategic transactions |
| ConAlliance | European mid-market healthcare cross-border boutique processes |
Investment Banks for Healthcare Deals: Descriptions & Reviews
FOCUS Investment Banking
FOCUS Investment Banking is built for sell-side execution. The team focuses on founder-owned and smaller private equity–backed healthcare businesses and runs a senior-led “quarterback” process designed to keep diligence tight, messaging precise, and buyer outreach competitive. FOCUS has closed 130+ transactions over the last decade, including recent healthcare transactions in provider services, animal health, distribution, pharmacy, laboratory and diagnostics, and healthcare technology. The firm is particularly active in provider services, and is one of the leading advisors to physician groups.
Healthcare deal volume & recency: Active in current-market healthcare sell-side work with repeat execution across subsectors.
Middle-market alignment: Purpose-built for mid-market companies where senior attention and process control drive outcomes.
Subsector coverage: Broad coverage across physicianservices, behavioral health, and other services and technology sectors.
Buyer network strength: Deep relationships with healthcare-focused PE and strategic consolidators.
Process transparency & thought leadership: Senior-led, seller-education approach and ongoing market visibility through updates and content.
Summary of Online Reviews |
|
Clients often describe FOCUS’s healthcare team as patient, highly responsive, and clear in how they explain each step of the process. One seller shared, “As physicians, there’s a lot we don’t fully understand about the business world. [The FOCUS team] was patient and did a great job explaining things throughout the transaction. I highly recommend working with them.” |
Houlihan Lokey
Houlihan Lokey is one of the most active healthcare M&A advisors globally in the sub-$1B market. Its advantage is deal volume, repeatable process management, and broad coverage that allows it to run competitive auctions across many healthcare business models.
Healthcare deal volume & recency: Top-tier pace and consistent closing activity in healthcare mid-market
Middle-market alignment: Strong fit for scaled mid-market processes, more institutional than boutique
Subsector coverage: Very broad across healthcare services, devices, HCIT, and life sciences-adjacent services
Buyer network strength: Extensive sponsor and strategic reach driven by constant market activity
Process transparency & thought leadership: Structured process and regular sector commentary, often more standardized than bespoke
Summary of Online Reviews |
|
Clients often describe Houlihan Lokey’s healthcare team as highly effective at driving competitive outcomes, frequently noting “outstanding results and a superior service level.” Sellers, particularly private equity–backed companies, highlight the firm’s ability to identify every relevant buyer and create bidding tension, with one CEO noting they “created a bidding war” that exceeded expectations. |
KeyBanc Capital Markets (Cain Brothers)
Cain Brothers is healthcare-focused and long-tenured in provider-heavy subsectors. It is often chosen when the seller wants a healthcare-only team that can speak fluently across provider dynamics, reimbursement complexity, and healthcare IT value drivers.
Healthcare deal volume & recency: High recent activity with consistent healthcare transaction flow
Middle-market alignment: Excellent fit for middle-market healthcare transactions and complex provider situations
Subsector coverage: Strong across providers, payors, HCIT, life sciences tools, and services
Buyer network strength: Deep ties with health systems and PE-backed consolidators
Process transparency & thought leadership: Known for preparation quality and clear process management
Summary of Online Reviews |
|
Clients often describe Cain Brothers as “industry insiders” who bring “deep industry knowledge” and a “holistic viewpoint” that clarifies strategic options. Sellers also note that the team runs a “highly professional sale process” and leverages “extensive buyer relationships” to secure multiple strong offers, resulting in outcomes that exceed expectations. |
Harris Williams
Harris Williams is a middle-market M&A advisor known for running competitive sell-side processes, often for sponsor-backed assets. It tends to perform best when the objective is broad buyer outreach and strong competitive tension in a defined timeline.
Healthcare deal volume & recency: Strong recent flow in healthcare services and tech-enabled models
Middle-market alignment: Excellent fit for $250M–$1B processes where dealcraft and pacing matter
Subsector coverage: Broad, with particularly strong services, outsourcing, HCIT, and pharma-services adjacency
Buyer network strength: Strong sponsor relationships and effective strategic outreach
Process transparency & thought leadership: Process-forward, highly structured execution with credible market insight
Summary of Online Reviews |
|
Clients often describe Harris Williams as “phenomenal” partners who run a “structured, highly professional process” and deliver results that “exceed expectations.” Sellers consistently point to the firm’s sector knowledge, global buyer network, and high-caliber advice as instrumental in securing multiple strong offers and finding the right long-term partner. |
Robert W. Baird & Co.
Baird is an employee-owned bank with broad healthcare coverage and a relationship-forward style. It is often a fit for teams that want steady process management, access to a wide buyer universe, and a partner that feels pragmatic rather than flashy.
Healthcare deal volume & recency: Consistent healthcare activity and steady transaction cadence
Middle-market alignment: Excellent for mid-market sellers who value partner-style advisory
Subsector coverage: Broad across HCIT, services, provider models, and biotech-adjacent categories
Buyer network strength: Strong access to sponsors and strategics through a wide platform reach
Process transparency & thought leadership: Collaborative process orientation and market insight sharing
Summary of Online Reviews |
|
Clients often describe Baird as a “true partnership” built on deep sector knowledge and an extensive industry network, noting that the team “knew all the key players” and kept them informed at every step. Sellers also highlight that Baird’s frequent dialogue with industry investors ensured “no stone was left unturned,” while still tailoring the process to fit the company’s culture. |
Rothschild & Co.
Rothschild is a global advisory firm with strong European depth and an independence-driven model. It can be a strong option for European healthcare mandates or cross-border work where an independent advisor is preferred.
Healthcare deal volume & recency: Strong, especially in Europe and broader EMEA activity
Middle-market alignment: Good for mid and upper-mid mandates, less tailored for lower-middle founder deals
Subsector coverage: Broad across healthcare sectors, often strongest where Europe has dense strategic buyers
Buyer network strength: Strong corporate and PE relationships with a Europe-weighted tilt
Process transparency & thought leadership: Process is typically high-touch, thought leadership is less public-facing
Summary of Online Reviews |
|
Clients often describe Rothschild as providing unbiased, client-first advice backed by deep regional expertise and a powerful network. One European healthcare CEO noted that Rothschild’s “long-standing presence and network gave us confidence,” adding that the firm delivered “both a high-value outcome and a smooth process.” |
J.P. Morgan
J.P. Morgan is a global bulge-bracket leader that dominates large-cap healthcare M&A. Its best fit is mega-deals, public-company transactions, and complex cross-border mandates where scale, financing capability, and global reach matter most.
Healthcare deal volume & recency: Excellent in high-value transactions
Middle-market alignment: Low for founder-led mid-market exits; more focused on large PE and bulge bracket clients
Subsector coverage: Extremely broad across pharma, biotech, devices, payors, and systems
Buyer network strength: Exceptional for global strategics and mega-funds
Process transparency & thought leadership: Strong research visibility and conference leadership, less intimate process feel for smaller sellers
Summary of Online Reviews |
|
Large healthcare clients often praise J.P. Morgan for its “sophisticated financing solutions” and “unparalleled global access,” particularly on complex, cross-border transactions. At the same time, some middle-market sellers note that the firm is “focused on strategic, large-cap mandates,” which can translate into a more institutional, less personalized experience for smaller deals. |
If you’d like to learn more about our healthcare investment banking services, reach out to Eric here.
